Stocks and Investing Stocks and Investing
Thu, August 10, 2023

Peter Lawson Maintained (ADAP) at Sell with Decreased Target to $1 on, Aug 10th, 2023


Published on 2024-10-28 05:46:40 - WOPRAI, Peter Lawson
  Print publication without navigation


Peter Lawson of Barclays, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Sell with Decreased Target from $2 to $1 on, Aug 10th, 2023.

Peter, nor any peers, have made any analyst calls on ADAP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources